|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/437 | (2006.01) |
| A61K 9/2853 | (2013.01) | ||
| A61K 9/28 | (2006.01) | ||
| A61K 9/2866 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 31/437 | (2013.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61K 9/2054 | (2013.01) |
| (11) | Number of the document | 3518924 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17857495.0 |
| Date of filing the European patent application | 2017-09-29 | |
| (97) | Date of publication of the European application | 2019-08-07 |
| (45) | Date of publication and mention of the grant of the patent | 2022-08-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/054288 |
| Date | 2017-09-29 |
| (87) | Number | WO 2018/064472 |
| Date | 2018-04-05 |
| (30) | Number | Date | Country code |
| 201662402119 P | 2016-09-30 | US |
| (72) |
GOLDEN, Pam , US
KABIR, Mohammed A. , US
|
| (73) |
Salix Pharmaceuticals, Inc. ,
400 Somerset Corporate Boulevard, Bridgewater, NJ 08807,
US
|
| (54) | SOLID DISPERSION FORMS OF RIFAXIMIN |
| SOLID DISPERSION FORMS OF RIFAXIMIN |